• Public Interest Law/Litigation

• 1.

Initiative for Medicines Access &Knowledge I-MAK Inc

We are a team of lawyers, scientists, and health experts challenging systemic injustice and advocating for health equity in drug development and access.

• Hospitals and Primary Medical Care Facilities

• 2.

Center for Medical Technology Policy

Center for Medical Technology Policy Home of #GPC (Green Park Collaborative), a multi-stakeholder forum developing #CoreOutcomeSets for clinical trial design.

Coriell Institute for Medical Research, Inc.

Nonprofit biomedical research center. Recognized as the world’s leading biobank, pioneer in genomic discovery, and expert in the field of stem cell research.

• Other Medical Research N.E.C.

• 4.

Transcelerate Biopharma Inc

TRANSCELERATE BIOPHARMA'S MISSION IS TO COLLABORATE ACROSS THE GLOBAL BIOPHARMACEUTICAL RESEARCH AND DEVELOPMENT COMMUNITY TO IDENTIFY, PRIORITIZE, DESIGN, AND FACILITATE THE IMPLEMENTATION OF SOLUTIONS DESIGNED TO DRIVE THE EFFICIENT, EFFECTIVE AND HIGH-QUALITY DELIVERY OF NEW MEDICINES.

I-ACT for Children

We act because every child with a medical need deserves the best chance possible.

• Promotion of Business (Chambers of Commerce)

• 6.

Scientists Advancing Affordable Medicines Inc

SCIENTISTS ADVANCING AFFORDABLE MEDICINES, INC.

NORTHWEST ASSOCIATION FOR BIOMEDICAL RESEARCH

TO PROMOTE THE PUBLIC'S TRUST OF BIOMEDICAL RESEARCH AND ITS ETHICAL CONDUCT Header Menu Be Part of the Conversation Join the USARO Initiative 2025 Clinical Research Professional Conference Registration opens soon Science Needs Champions.

• Professional Societies & Associations

• 8.

Pharmacogenomics Research Network Inc

WildApricot by @Personifycorp helps over 32,000 membership organizations with an all-in-one solution.

• Promotion of Business (Chambers of Commerce)

• 9.

INDUSTRY PHARMACOGENOMICS WORKING GROUP

Welcome To The Pharmacogenomic Working Group The Industry Pharmacogenomics Working Group IPWG is an association of pharmaceutical and biotech companies who are actively engaged in the field of pharmacogenomic PGx research.